Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ladanyi

Showing results (21-30 of 569) with videos related to

Pageof 57
Sort By:
Plos Medicine|December 28, 2016
Cancer Genomics: Large-Scale Projects Translate into Therapeutic AdvancesElaine R Mardis, Marc Ladanyi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmationLeonard H Wexler, Marc Ladanyi
The Journal of Molecular Diagnostics : JMD|October 4, 2008
KRAS mutations: an old oncogene becomes a new predictive biomarkerGregory J Riely, Marc Ladanyi
Annual Review of Pathology|September 28, 2011
Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targetsStephen L Lessnick, Marc Ladanyi
Nature Genetics|September 27, 2012
Bringing the genomic landscape of small-cell lung cancer into focusM Catherine Pietanza, Marc Ladanyi
The Journal of Pathology|November 18, 2010
Cancer biology and genomics: translating discoveries, transforming pathologyMarc Ladanyi, Pancras C W Hogendoorn
Cancer Research|July 20, 2006
SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcomaTsuyoshi Saito, Makoto Nagai, Marc Ladanyi
The Journal of Molecular Diagnostics : JMD|January 23, 2010
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFRMarie Brevet, Maria Arcila, Marc Ladanyi
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomasQiulu Pan, William Pao, Marc Ladanyi
Genome Medicine|March 28, 2019
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesotheliomaMarc Ladanyi, Francisco Sanchez Vega, Marjorie Zauderer
Pageof 57

Showing results (21-30 of 569) with videos related to

Sort By:
Pageof 57
Plos Medicine|December 28, 2016
Cancer Genomics: Large-Scale Projects Translate into Therapeutic AdvancesElaine R Mardis, Marc Ladanyi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmationLeonard H Wexler, Marc Ladanyi
The Journal of Molecular Diagnostics : JMD|October 4, 2008
KRAS mutations: an old oncogene becomes a new predictive biomarkerGregory J Riely, Marc Ladanyi
Annual Review of Pathology|September 28, 2011
Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targetsStephen L Lessnick, Marc Ladanyi
Nature Genetics|September 27, 2012
Bringing the genomic landscape of small-cell lung cancer into focusM Catherine Pietanza, Marc Ladanyi
The Journal of Pathology|November 18, 2010
Cancer biology and genomics: translating discoveries, transforming pathologyMarc Ladanyi, Pancras C W Hogendoorn
Cancer Research|July 20, 2006
SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcomaTsuyoshi Saito, Makoto Nagai, Marc Ladanyi
The Journal of Molecular Diagnostics : JMD|January 23, 2010
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFRMarie Brevet, Maria Arcila, Marc Ladanyi
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomasQiulu Pan, William Pao, Marc Ladanyi
Genome Medicine|March 28, 2019
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesotheliomaMarc Ladanyi, Francisco Sanchez Vega, Marjorie Zauderer
Pageof 57